
CENNA BIOSCIENCES INC
Developing Disease-Modifying Drugs for Alzheimer's Disease
SAN DIEGO, United States · Founded 2016 · $1.0M raised
- Headquarters
- SAN DIEGO, California
- Founded
- 2016
- Business Model
- B2G
- Website
- cennabiosciences.com
- Total Funding
- $1.0M
- Last Round
- $1.0M GrantJan 2025
About
Cenna Biosciences is a privately-held biopharmaceutical company based in La Jolla, California, focused on developing novel disease-modifying treatments for Alzheimer's disease. Their lead drug candidate, Nubytide, is a proprietary peptide therapy that inhibits beta amyloid (Aß) production and reduces markers of inflammation and Tau pathology. Cenna has secured multiple NIH SBIR grants including a $2.7M Phase II award from the National Institute on Aging.
Summary
CENNA BIOSCIENCES INC is a Biotech company based in SAN DIEGO, United States, founded in 2016. It has raised $1.0M in total, most recently a $1.0M Grant round in Jan 2025.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform

Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.